XML 31 R23.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Balance Sheet Details (Tables)
6 Months Ended
Jun. 30, 2024
Consolidated Balance Sheet [Abstract]  
Summary of Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):

 

 

 

June 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Internal-use software

 

$

491

 

 

$

491

 

Leasehold improvements

 

 

283

 

 

 

 

Laboratory equipment

 

 

144

 

 

 

178

 

Furniture and fixtures

 

 

92

 

 

 

137

 

Computer hardware and software

 

 

58

 

 

 

58

 

Construction in progress

 

 

36

 

 

 

157

 

Property and equipment, gross

 

 

1,104

 

 

 

1,021

 

Less: accumulated depreciation

 

 

(342

)

 

 

(259

)

Property and equipment, net

 

$

762

 

 

$

762

 

Summary of Accrued Expenses

Accrued expenses consisted of the following (in thousands):

 

 

 

June 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Accrued research and development costs

 

$

1,715

 

 

$

1,868

 

Accrued clinical trial costs

 

 

4,512

 

 

 

4,831

 

Accrued payroll liabilities

 

 

3,147

 

 

 

7,742

 

Other accrued liabilities

 

 

1,010

 

 

 

984

 

Accrued related party liabilities

 

 

166

 

 

 

83

 

Total accrued expenses

 

$

10,550

 

 

$

15,508

 

Summary of Accrued Severance Costs A summary of accrued severance costs associated with the RIF as of June 30, 2024 is shown in the table below (in thousands):

 

 

 

June 30,

 

 

 

2024

 

Accrued severance costs as of December 31, 2023

 

$

2,178

 

Reduction in estimate for continued healthcare benefits

 

 

(113

)

Cash payments

 

 

(1,975

)

Accrued severance costs as of June 30, 2024

 

$

90